Consequences of peripheral vasculopathy, including Raynaud’s phenomenon, had been noticed in postmarketing studies and in the therapeutic dosages of CNS stimulants in all age groups throughout the program of treatment method. Indications and signs or symptoms commonly improved right after dosage reduction or discontinuation in the CNS stimulant.N